2015
DOI: 10.3389/fbioe.2015.00041
|View full text |Cite
|
Sign up to set email alerts
|

Novel Cycloheximide Derivatives Targeting the Moonlighting Protein Mip Exhibit Specific Antimicrobial Activity Against Legionella pneumophila

Abstract: Macrophage infectivity potentiator (Mip) and Mip-like proteins are virulence factors in a wide range of pathogens including Legionella pneumophila. These proteins belong to the FK506 binding protein (FKBP) family of peptidyl-prolyl-cis/trans-isomerases (PPIases). In L. pneumophila, the PPIase activity of Mip is required for invasion of macrophages, transmigration through an in vitro lung–epithelial barrier, and full virulence in the guinea pig infection model. Additionally, Mip is a moonlighting protein that b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
18
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(20 citation statements)
references
References 36 publications
2
18
0
Order By: Relevance
“…These derivatives displayed lower IC 50 values and improved selectivity for MIP (although FKBP12 was still 10-fold better inhibited) and inhibited bacterial growth in liquid culture. Notably, the effect was independent of MIP, since the same effect was shown in Δ mip -mutants (Rasch et al, 2015).…”
Section: Microbial Fkbpsmentioning
confidence: 70%
“…These derivatives displayed lower IC 50 values and improved selectivity for MIP (although FKBP12 was still 10-fold better inhibited) and inhibited bacterial growth in liquid culture. Notably, the effect was independent of MIP, since the same effect was shown in Δ mip -mutants (Rasch et al, 2015).…”
Section: Microbial Fkbpsmentioning
confidence: 70%
“…Infection of a THP-1 macrophage-like cell line with L. pneumophila. To analyze the intracellular replication of L. pneumophila mutant strains in human macrophages, the acute monocytic leukemia cell line THP-1 (DSMZ ACC16) was used (59). The cells were adjusted to 5 ϫ 10 5 cells/ml in cell culture medium (RPMI 1640, 2 mM L-glutamine, 10% fetal calf serum [FCS]) supplemented with 100 nM phorbol-12-myristate-13-acetate (PMA) for differentiation into macrophage-like cells.…”
Section: Methodsmentioning
confidence: 99%
“…124 Recently, this work has been expanded to test the cycloheximide scaffold and its derivatives as novel antibacterial agents. 125 …”
Section: Inhibitors Of Fkbpsmentioning
confidence: 99%